Extractables and Leachables Testing

 

Regulatory agencies require biopharmaceutical manufacturers who utilize drug delivery devices, single-use manufacturing systems, and container closure apparatuses to submit toxicological Risk Assessments based on chemistry data generated by extractables and leachables testing. All testing is designed to support drug manufacturers from early stages through to commercial batch release in compliance with ICH guidelines and FDA/EMA regulations.

Through investment in technology and expertise, we have developed a multi-tiered analytical methodology to extractables and leachables testing that provides complete chemical characterization, enabling accurate assessment of any potential hazards.

Our Approach to Complete Chemical Characterization and Risk Assessment

Consultation

Our experts meet with you to gain a thorough understanding of your product and process such as testing objectives, past experiences with outsourcing, materials, patient population, route of administration, and exposure.

Protocol Selection

Select preferred industry study protocol; BPOG, BPSA, USP 665, or hybrid. Watch an on-demand webinar that demonstrates our approach to designing a modified BPOG protocol. 

Testing - Full Range of Chemical Detection

Test maximum limits of extractable chemicals utilizing the following instrumentation

  • Headspace Gas Chromatography (with mass spectrometry) for analysis of volatile organic compounds
  • Direct inject gas chromatography (with MS) for analysis of semi-volatile organic compounds
  • Liquid Chromatography (with MS) for analysis of non-volatile organic compounds
  • Inductively coupled plasma for elemental analysis

Chemical Identification

Leverage proprietary LC/MS database, commercial databases, literature, and mass accurate data to search, match and identify all chemicals detected.

Risk Assessment Report

As specified in ISO 10993, manufacturers must determination of the suitability of a container, packaging, or single-use system for a particular application involves balancing any identified risks with the clinical benefit to the patient associated with its desired purpose.

Toxicology Risk Assessments evaluate the safety of chemicals identified through the full material characterization offered by our Analytical Chemistry department. Our team of toxicologists will utilize the data generated by our laboratory and database analysis to assess tolerable exposure levels.

Develop, manufacture, and release your advanced therapies faster and with greater predictability.

 

Click below to speak to a technical specialist today